Gesynta Pharma
$31.2M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Gesynta Pharma is currently valued at N/A as of January 20, 2025. The company has raised a total of $61.6M in funding.
Investment Perspective
Gesynta Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Gesynta Pharma Worth in 2025?
As of 2025, Gesynta Pharma is valued at N/A, based on the company's Later Stage VC funding round in January 20, 2025. This valuation positions Gesynta Pharma as one of the leading private companies in the sector.
Gesynta Pharma Valuation History
Gesynta Pharma's funding history demonstrates steady growth and investor confidence.
How Gesynta Pharma Valuation is Determined
Private company valuations like Gesynta Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Gesynta Pharma Valuation FAQs
Is Gesynta Pharma profitable?
Gesynta Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Gesynta Pharma's valuation compare to competitors?
Gesynta Pharma is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Gesynta Pharma IPO?
Gesynta Pharma has not announced plans for an initial public offering. Until an IPO, investors can access Gesynta Pharma shares through secondary market platforms.